Amazon Made GLP-1s $25/Month. The Real Seller Opportunity Is What These Customers Buy Next.

Amazon News Seller Strategy Health and Wellness Catalog Optimization

Amazon launched a national GLP-1 subscription program at $25 a month. Sellers can't list the drugs. The opportunity is in everything these customers buy once they start taking them.

What GLP-1 users actually buy

Amazon launched a national GLP-1 management program last week, putting weight loss drugs like Wegovy and Zepbound on a primary care subscription starting at $25 per month with insurance through Amazon One Medical and Amazon Pharmacy. Hims and Hers stock dropped 6% on the news.

For most Amazon sellers, the natural reaction is to scroll past it. Sellers can't list Wegovy or Zepbound on the marketplace. These are prescription drugs, and Amazon Pharmacy is the only channel for them. There's no direct market for FBA sellers in the weight loss drug itself.

That's not the story. The story is what GLP-1 users buy when they're not buying drugs.

Behavior Shift	Change vs. Pre-GLP-1	Direction
Protein consumption	Up 65%	Strong Increase
Fruit and vegetable consumption	Up nearly 80%	Strong Increase
Snack categories	Down 40 to 60%	Sharp Decline
Sweets, salty snacks, sugary drinks	Down across the board	Sharp Decline
Willingness to pay for quality health products	80% say yes	High Intent

Source: EY-Parthenon survey data on active GLP-1 users. ADM research for willingness-to-pay figure.

The side effects of the medication drive their own demand. Muscle loss is common, pushing demand for high-protein supplements, BCAAs, creatine, and collagen. Constipation and digestive issues drive demand for fiber, probiotics, and microbiome supplements. Hydration matters more than usual, growing the electrolyte and rehydration category. Skin elasticity changes pull spend toward beauty and personal care products focused on hydration and collagen support. B-vitamin deficiency is common with reduced food intake, so multivitamins and targeted supplementation are growing.

$25 Monthly GLP-1 subscription price with insurance via Amazon

23% Share of US food and bev sales from GLP-1 households today

35% Circana projection for that share by 2030

The cohort isn't shrinking the pie. It's reshaping it. The volume of what GLP-1 users buy drops, but the willingness to pay for quality goes up. ADM's research found that 80% of active GLP-1 users are willing to spend more on products that offer additional health benefits beyond basic nutrition.

Why Amazon's position is unique

Amazon now operates the prescription, the delivery, and the marketplace where these users buy adjacent products. No other retailer has all three. Walmart sells the drugs but doesn't have an ad platform at Amazon's scale. Hims and Ro sell the drugs but don't have a third-party marketplace.

Amazon Pharmacy is HIPAA-protected, so the prescription data itself doesn't flow into ad targeting or product recommendations. That's not the point. The point is that Amazon's retail side already sees the behavioral signature of GLP-1 users from search queries and purchase patterns: high-protein, low-sugar, electrolyte-heavy, supplement-heavy, smaller-portion. As the cohort grows, that behavioral pattern is what drives "frequently bought together" recommendations, ad targeting, and Rufus answers, regardless of what's on anyone's prescription.

The AI-driven discovery surfaces that decide what shoppers see are where this signal will compound first. You don't need prescription data. You need your listing to be structurally ready for the search behavior the cohort generates.

The audit to run this quarter

If you sell in protein, hydration, supplements, or health-adjacent personal care, this is the work to do right now.

1. 1
   Pull your search term reports. Look for Ozempic, Wegovy, Zepbound, semaglutide, GLP-1, "high protein," "muscle preservation," and adjacent terms. If they're showing up, they're already routing traffic to your listings. Most sellers haven't checked.
2. 2
   Audit your listing copy for benefit alignment. GLP-1 users care about specific things: high protein per serving, low sugar, electrolyte content, fiber content, muscle support, microbiome support, satiety, hydration. If your product genuinely delivers on any of those, your title, bullets, and A+ content should say so explicitly. No medical claims. Just benefit language that matches the cohort's actual needs.
3. 3
   Check your attribute structure. Amazon's benefit attributes feed into structured search and Rufus answers. Products tagged "high protein" or "low sugar" surface in cohort-relevant queries that products without those tags don't.
4. 4
   Tighten your assortment around the buyer, not the SKU. Cut catalog sprawl. Double down on the SKUs that align with where the buyer is going. Stop trying to serve everyone with everything.

The bottom line

Amazon's $25 GLP-1 program isn't a seller opportunity. It's a cohort accelerator. The opportunity is in the protein bar already in your catalog, the electrolyte drink that needs better positioning, the supplement that should have been calling out muscle preservation in its A+ content six months ago.

The drug is the headline. The cohort is the story.

Turn behavioral shifts into ad performance before your competitors do

Astra's keyword harvesting surfaces emerging search patterns early and builds them into your campaigns automatically. When a cohort shifts, your ad coverage shifts with it.

Book a Free Strategy Call Try Self-Service Try Managed Edition

Table of Contents

1. What GLP-1 users actually buy
2. Why Amazon's position is unique
3. The audit to run this quarter
4. The bottom line

Key Takeaways

What sellers need to know

• The opportunity isn't in the drug. Sellers can't list GLP-1 prescriptions. The opportunity is in the behavioral shift these customers make across protein, supplements, hydration, and health-adjacent categories.
• GLP-1 households already represent 23% of US food and bev sales. Circana projects that share hits 35% by 2030. This is not a niche segment.
• Amazon owns all three layers. Prescription, delivery, and marketplace. No other retailer has that combination, which means the behavioral signal compounds on Amazon faster than anywhere else.
• Search term reports are the fastest audit. Check for GLP-1 adjacent terms now. If they're routing traffic, you're already in the cohort's consideration set and most sellers don't know it.
• Benefit language in listing copy is the primary lever. Protein per serving, electrolyte content, fiber, muscle support. If your product delivers on these, your A+ content should say so clearly.

---

---

---